Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Andrx raises $248.9 million

ADRX raised $248.9 million through the sale of 5.2 million shares at $48. Watson

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE